NeuroscienceMolecular TherapyPeer-reviewed
A novel multiplex RNAi therapy simultaneously targets Hif1a and Hif2a to defy retinal degeneration in two models of AMD
Lynn J. A. Ebner, Cornelia Imsand, Duygu Karademir…·Marijana Samardzija
This paper develops a dual-acting RNAi therapy targeting Hif1a and Hif2a to protect retinal cells in AMD models, showing superior efficacy compared to single-target therapies.
1 citation